ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pogrebniak, H. W.
Right arrow Articles by Pass, H. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pogrebniak, H. W.
Right arrow Articles by Pass, H. I.

The Annals of Thoracic Surgery, Vol 54, 33-38, Copyright © 1992 by The Society of Thoracic Surgeons

ARTICLES

Renal cell carcinoma: resection of solitary and multiple metastases

HW Pogrebniak, G Haas, WM Linehan, SA Rosenberg and HI Pass
Thoracic Oncology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Between 1985 and 1991, 23 patients underwent resection of pulmonary metastases from renal cell carcinoma, of whom 18 had previously received interleukin-2 based immunotherapies. Mean survival from exploration in all patients was 43 months. Survival after resection did not correlate with the number of nodules on preoperative tomograms, the number of nodules resected, or the disease-free interval. Patients who underwent complete resection of metastatic disease (n = 15), however, had a significantly longer survival (mean, 49 months; median not yet achieved) compared with patients with incomplete resection (median, 16 months) (p2 = 0.02). Two of the 15 patients who underwent curative resections are presently free of disease greater than 45 months after exploration. These data support surgical resection of isolated pulmonary metastatic disease from renal cell cancer.


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
J. Assouad, B. Petkova, P. Berna, A. Dujon, C. Foucault, and M. Riquet
Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors
Ann. Thorac. Surg., October 1, 2007; 84(4): 1114 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Pfannschmidt, H. Hoffmann, T. Muley, S. Krysa, C. Trainer, and H. Dienemann
Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma
Ann. Thorac. Surg., November 1, 2002; 74(5): 1653 - 1657.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. Piltz, G. Meimarakis, M. W. Wichmann, R. Hatz, F. W. Schildberg, and H. Fuerst
Long-term results after pulmonary resection of renal cell carcinoma metastases
Ann. Thorac. Surg., April 1, 2002; 73(4): 1082 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
K. Z'graggen, C. Fernandez-del Castillo, D. W. Rattner, H. Sigala, and A. L. Warshaw
Metastases to the Pancreas and Their Surgical Extirpation
Arch Surg, April 1, 1998; 133(4): 413 - 418.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.